Sign In
Buy COR
$263.64
-1.20 (-0.453%)
At Close: Jun 03, 2026
Pharma giant Cencora is alerting millions about its data breach
10:45am, Friday, 02'nd Aug 2024
Cencora has so far notified over a million people around the U.S. that their personal and protected health information was compromised in a data breach earlier this year, TechCrunch has found.
Walgreens Sells Another Stake In Distributor Cencora For $1.1 Billion
07:29pm, Thursday, 01'st Aug 2024
Walgreens Boots Alliance has sold more shares of drug distributor Cencora for proceeds of about $1.1 billion, which will be used “primarily for debt paydown and general corporate purposes.”
Walgreens further reduces stake in Cencora
06:20pm, Thursday, 01'st Aug 2024
Walgreens Boots Alliance said on Thursday it has sold shares in drug distributor Cencora for proceeds of about $1.1 billion.
Compared to Estimates, Cencora (COR) Q3 Earnings: A Look at Key Metrics
09:30pm, Wednesday, 31'st Jul 2024
The headline numbers for Cencora (COR) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates
Cencora says additional data stolen in February cyberattack
06:14pm, Wednesday, 31'st Jul 2024
U.S. drug distributor Cencora said on Wednesday additional data on patients, beyond what was initially identified, had been stolen in a cyberattack and data breach that happened in February.
Cencora (COR) Q3 Earnings Beat Estimates, '24 View Raised
02:57pm, Wednesday, 31'st Jul 2024
Cencora's (COR) third-quarter fiscal 2024 results benefit from overall market growth, including rising demand for GLP-1 drugs and COVID-19 vaccines. Inflationary pressure remains.
Cencora, Inc. (COR) Q3 2024 Earnings Call Transcript
11:12am, Wednesday, 31'st Jul 2024
Cencora, Inc. (NYSE:COR ) Q3 2024 Earnings Conference Call July 31, 2024 8:30 AM ET Company Participants Bennett Murphy - Senior Vice President, Head of Investor Relations & Treasury Steve Collis - Ch
Cencora (COR) Surpasses Q3 Earnings and Revenue Estimates
08:41am, Wednesday, 31'st Jul 2024
Cencora (COR) came out with quarterly earnings of $3.34 per share, beating the Zacks Consensus Estimate of $3.18 per share. This compares to earnings of $2.92 per share a year ago.
Will These 4 MedTech Stocks Beat Forecasts This Earnings Season?
02:35pm, Tuesday, 30'th Jul 2024
Medical Device companies' quarterly results are likely to reflect strength in customer demand. Let's see how COR, XRAY, GEHC and GKOS are placed ahead of their earnings release.
Why Cencora (COR) is a Top Momentum Stock for the Long-Term
10:50am, Tuesday, 30'th Jul 2024
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Here's Why Cencora (COR) is a Strong Value Stock
10:40am, Monday, 29'th Jul 2024
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Countdown to Cencora (COR) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS
10:21am, Monday, 29'th Jul 2024
Evaluate the expected performance of Cencora (COR) for the quarter ended June 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for
Cencora (COR) to Report Q3 Earnings: Is a Beat in Store?
10:00am, Monday, 29'th Jul 2024
Cencora's (COR) third-quarter fiscal 2024 results are likely to reflect solid performance in the U.S. Healthcare Solutions segment.
Cencora (COR) Reports Next Week: Wall Street Expects Earnings Growth
11:06am, Wednesday, 24'th Jul 2024
Cencora (COR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Cencora (COR) is a Top Value Stock for the Long-Term
10:41am, Friday, 12'th Jul 2024
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
